Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. Founded in 2016, Siolta Therapeutics is backed by investors that include Global Brain Corporation, Marc Benioff, Khosla Ventures, Seventure Partners, and SymBiosis LLC and is headquartered in San Francisco.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
